HS2s Cost Ballooning to 1027bn and Delays to 2039 Raise Fresh Questions Over UK Infrastructure Spending Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal Trump Urges Caution on Iran Ceasefire Deal Amid Republican Warnings of Potential Economic Fallout BofA Analyst Raises Philip Morris International Price Target Signaling Confidence in SmokeFree Strategy Germany Signs Major Canadian LNG Agreement Amid Energy Security Concerns French Open 2026 Player Dispute From Boycott Threat to Media Protest Financial Implications for Tennis BEAM Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response ST Bancorp Inc Q1 2026 Earnings Earnings Beat Driven by Strong Net Interest Margin CLIR Q1 2026 Earnings EPS Misses Estimates as Company Navigates Development Stage AGNC Q1 2026 Earnings EPS Surges Past Estimates as Stock Gains Ground Ero Copper Corp Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance KUST Q4 2025 Earnings Deep EPS Miss Highlights Operational Challenges 1RT Acquisition Corp Units ONCHU Edges Higher Amid Consolidation Near Support Silexion Therapeutics SLXN Slips 3 as Stock Approaches Key Support at 040 Eagle Materials EXP Holds Steady Near Support After Modest Uptick Agios Pharmaceuticals Surges 629 Key Levels to Watch for AGIO Stock Volato Group SOAR Slides 5 as Stock Tests Key Support at 013 Costcos Gas Stations Gain Traction as Soaring Fuel Prices Drive Frugal Shoppers WEX Q1 2026 Earnings EPS Beats Estimates by 101 Shares Edge Higher Sotherly Hotels Preferred Stock SOHON Holds Steady Near Support Levels GTEC Q4 2025 Earnings Significant EPS Miss Despite Slight Stock Uptick SSR Mining Q1 2026 Earnings EPS Surges Past Estimates by 318 as Stock Declines AKTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development RKT Q1 2026 Earnings EPS Surpasses Estimates by 256 Amid Challenging Market CVI Q1 2026 Earnings Deep Losses and Wide Miss Signal Challenging Refining Environment JOE Q1 2026 Earnings Modest EPS Performance Amid Limited Financial Disclosures Serina Therapeutics Q1 2026 Earnings EPS Misses Estimates as Stock Climbs Despite Loss